Moreover, AGE treatment inhibited inflammatory response to prevent atherosclerosis by reducing the serum level of C-reactive protein and thromboxane B-2, the protein level of TNF-α and IL-1 receptor-associated kinase 4, and increasing AMPK activity in the liver of apolipoprotein E-knockout mice [47]. The gene discussed is APOE; the disease is atherosclerosis.